What’s new

• Company Secretary and Compliance Officer Narendra D. Shah resigns for personal reasons.
• Resignation effective after working hours on July 1, 2026.
• Board has started shortlisting a successor.

Why it matters

For a ₹59 cr market-cap firm, any KMP departure draws attention, but this one is routine, amicable, and effective over a year away. No disruption to operations or compliance is expected.

What we’re watching

• Whether the successor is named before the effective date.
• Any further board-level changes in the interim.

The full read

Conart Engineers' Company Secretary, Narendra D. Shah, is leaving after working hours on July 1, 2026, citing personal reasons. The board has already started looking for a replacement and says it will meet regulatory deadlines. For a ₹59 cr nano-cap, any KMP departure gets a second glance, but this one is amicable and far in the future — not a crisis. Routine, not disruptive.

Primary source: BSE · NSE

What’s new

• Full-year revenue grew 10% to ₹62.23 crore; net profit rose 39% to ₹3.73 crore.
• Fourth-quarter revenue fell 29% to ₹15.61 crore, but quarterly profit was steady.
• Auditor issued a clean, unmodified opinion on the annual financials.

Why it matters

A 29% quarterly revenue drop is material for a ₹67-crore company. Profit held only because costs fell in tandem. The filing offers no strategic context or guidance, leaving the Q4 decline as an open question.

What we’re watching

• Whether Q4's revenue drop is a one-off or a trend.
• Any explanation for the cost control that preserved profit.
• The stock's reaction, given its thin liquidity.

The full read

Conart Engineers posted a clean year. Revenue reached ₹62.23 crore, up 10%, and profit jumped 39% to ₹3.73 crore. The final quarter was the problem. Q4 revenue fell 29% to ₹15.61 crore. Profit held. For a ₹67-crore nano-cap, that divergence demands an explanation. None was offered. This is a standard compliance filing. No new orders. No strategy. No guidance. Just the numbers, and a quarterly revenue drop that sits uncomfortably against the annual growth story. Hardly actionable.

Primary source: BSE · NSE

What’s new

• Conart Engineers won a civil and structural construction order from Apothecon Pharmaceuticals.
• The project is located at the PO Dabhasa site in Vadodara, Gujarat.
• Execution is slated for completion within 12 months.

Why it matters

For a company with a market valuation of only ₹66 crore, a ₹15.41 crore order is a material shift in scale. It represents over 23% of the firm's total market value and provides a clear revenue runway for the next year.

What we’re watching

• Whether the company can maintain margins on this project given the competitive nature of civil work.
• The pace of execution at the PO Dabhasa site over the coming quarters.
• Any further order wins in the industrial infrastructure segment.

The full read

Conart Engineers has locked in a ₹15.41 crore civil construction contract from Apothecon Pharmaceuticals. The project, located at the PO Dabhasa site in Vadodara, involves civil and structural work for the LVAPI-6 Services facility.

It is a massive win.

For a nano-cap firm valued at ₹66 crore, this contract represents more than 23% of the company's total market capitalization and provides a clear revenue stream for the next 12 months, which effectively secures a significant portion of its annual turnover and reinforces its footprint in the industrial infrastructure segment.

Primary source: BSE · NSE